Star Health Share Price Jump Up To 13% After Q4 FY26 Results: Net Profit Up ₹111 Crore

Star Health and Allied Insurance share price moved sharply higher after the company announced its financial results for the quarter and year ended March 31, 2026.

The stock climbed as much as 13.3% to an intraday high of ₹586.25 on the NSE. Later, it traded around ₹537, still up nearly 4%, outperforming the broader market.

Star Health Net Profit And Premium Growth Remain Strong

The insurer reported a profit after tax (PAT) of ₹911 crore for FY26, showing a 16% year-on-year increase. Growth was supported by:

• Higher premium collections
• Better customer renewals
• Lower loss ratio
• Improved operating efficiency

For FY26:

• Gross Written Premium (GWP): ₹20,369 crore (up 16% YoY)
• Retail health premium: ₹19,341 crore (up 20% YoY)
• Retail health market share: 31%

Operating Metrics Show Improvement

The company’s efficiency and risk metrics improved notably:

• FY26 combined ratio: 98.8% vs 101.1% last year
• Q4 combined ratio: 95.7% vs 98.4% YoY
• Loss ratio improved for the third straight quarter

These numbers indicate better underwriting and cost control.

Also Read: Varun Beverages Q1 CY2026 PAT Jumps 20% YoY!

Management Outlook 

Management highlighted disciplined execution, digital adoption, and strong focus on retail health insurance as key growth drivers.

About Star Health and Allied Insurance Company

Star Health & Allied Insurance Ltd was India’s first standalone health insurance company and remains the country’s largest private health insurer. In FY21, it held a 15.8% share of the overall Indian health insurance market and maintained strong leadership in the retail health segment.

Star Health and Allied Insurance Company Share Price Movement

Star Health and Allied Insurance Company share price closed at ₹532.80 on April 29, 2026, rising ₹15.50 or 3.00% for the day. The stock opened at ₹543.25 and touched an intraday high of ₹586.25 and a low of ₹532.15. Over the past year, the stock has moved between a 52-week high of ₹586.25 and a 52-week low of ₹348.30, and the company has not announced any dividend recently.

Conclusion

Strong earnings and improving operating metrics helped boost Star Health’s stock. The company remains well-positioned to benefit from rising demand for health insurance in India.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.